4-[5-[[(1S)-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-1-yl]methyl]-2,3,4-trimethoxyphenoxy]-6-[(3,4-dimethoxyphenyl)methyl]-[1,3]dioxolo[4,5-f]isoquinoline
Internal ID | 91bd34f5-0ab1-43fc-af5f-d25567993a66 |
Taxonomy | Organoheterocyclic compounds > Isoquinolines and derivatives > Benzylisoquinolines |
IUPAC Name | 4-[5-[[(1S)-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-1-yl]methyl]-2,3,4-trimethoxyphenoxy]-6-[(3,4-dimethoxyphenyl)methyl]-[1,3]dioxolo[4,5-f]isoquinoline |
SMILES (Canonical) | CN1CCC2=CC(=C(C=C2C1CC3=CC(=C(C(=C3OC)OC)OC)OC4=C5C(=C6C=CN=C(C6=C4)CC7=CC(=C(C=C7)OC)OC)OCO5)OC)OC |
SMILES (Isomeric) | CN1CCC2=CC(=C(C=C2[C@@H]1CC3=CC(=C(C(=C3OC)OC)OC)OC4=C5C(=C6C=CN=C(C6=C4)CC7=CC(=C(C=C7)OC)OC)OCO5)OC)OC |
InChI | InChI=1S/C41H44N2O10/c1-43-14-12-24-18-33(46-4)34(47-5)20-27(24)30(43)17-25-19-35(39(49-7)41(50-8)37(25)48-6)53-36-21-28-26(38-40(36)52-22-51-38)11-13-42-29(28)15-23-9-10-31(44-2)32(16-23)45-3/h9-11,13,16,18-21,30H,12,14-15,17,22H2,1-8H3/t30-/m0/s1 |
InChI Key | AJJLNXPVHBPQJA-PMERELPUSA-N |
Popularity | 1 reference in papers |
Molecular Formula | C41H44N2O10 |
Molecular Weight | 724.80 g/mol |
Exact Mass | 724.29959560 g/mol |
Topological Polar Surface Area (TPSA) | 108.00 Ų |
XlogP | 7.10 |
Atomic LogP (AlogP) | 7.18 |
H-Bond Acceptor | 12 |
H-Bond Donor | 0 |
Rotatable Bonds | 13 |
There are no found synonyms. |
![2D Structure of 4-[5-[[(1S)-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-1-yl]methyl]-2,3,4-trimethoxyphenoxy]-6-[(3,4-dimethoxyphenyl)methyl]-[1,3]dioxolo[4,5-f]isoquinoline 2D Structure of 4-[5-[[(1S)-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-1-yl]methyl]-2,3,4-trimethoxyphenoxy]-6-[(3,4-dimethoxyphenyl)methyl]-[1,3]dioxolo[4,5-f]isoquinoline](https://plantaedb.com/storage/docs/compounds/2023/11/61ed5cf0-842c-11ee-9038-cf9bde3d2a29.jpg)
Target | Value | Probability (raw) | Probability (%) |
---|---|---|---|
Human Intestinal Absorption | + | 0.9116 | 91.16% |
Caco-2 | - | 0.7492 | 74.92% |
Blood Brain Barrier | + | 0.8500 | 85.00% |
Human oral bioavailability | - | 0.5571 | 55.71% |
Subcellular localzation | Mitochondria | 0.3520 | 35.20% |
OATP2B1 inhibitior | + | 0.5801 | 58.01% |
OATP1B1 inhibitior | + | 0.9071 | 90.71% |
OATP1B3 inhibitior | + | 0.9325 | 93.25% |
MATE1 inhibitior | - | 0.8000 | 80.00% |
OCT2 inhibitior | + | 0.5500 | 55.00% |
BSEP inhibitior | + | 0.9899 | 98.99% |
P-glycoprotein inhibitior | + | 0.9248 | 92.48% |
P-glycoprotein substrate | + | 0.8112 | 81.12% |
CYP3A4 substrate | + | 0.7029 | 70.29% |
CYP2C9 substrate | - | 0.6036 | 60.36% |
CYP2D6 substrate | + | 0.5641 | 56.41% |
CYP3A4 inhibition | + | 0.6451 | 64.51% |
CYP2C9 inhibition | - | 0.8528 | 85.28% |
CYP2C19 inhibition | - | 0.6605 | 66.05% |
CYP2D6 inhibition | - | 0.6600 | 66.00% |
CYP1A2 inhibition | - | 0.7390 | 73.90% |
CYP2C8 inhibition | + | 0.7751 | 77.51% |
CYP inhibitory promiscuity | + | 0.7246 | 72.46% |
UGT catelyzed | - | 0.0000 | 0.00% |
Carcinogenicity (binary) | - | 0.9800 | 98.00% |
Carcinogenicity (trinary) | Non-required | 0.5875 | 58.75% |
Eye corrosion | - | 0.9904 | 99.04% |
Eye irritation | - | 0.9295 | 92.95% |
Skin irritation | - | 0.8180 | 81.80% |
Skin corrosion | - | 0.9523 | 95.23% |
Ames mutagenesis | + | 0.6200 | 62.00% |
Human Ether-a-go-go-Related Gene inhibition | + | 0.8776 | 87.76% |
Micronuclear | - | 0.5200 | 52.00% |
Hepatotoxicity | - | 0.6350 | 63.50% |
skin sensitisation | - | 0.8823 | 88.23% |
Respiratory toxicity | + | 0.7444 | 74.44% |
Reproductive toxicity | + | 0.8778 | 87.78% |
Mitochondrial toxicity | + | 0.7625 | 76.25% |
Nephrotoxicity | - | 0.8806 | 88.06% |
Acute Oral Toxicity (c) | III | 0.7722 | 77.22% |
Estrogen receptor binding | + | 0.8605 | 86.05% |
Androgen receptor binding | + | 0.6681 | 66.81% |
Thyroid receptor binding | + | 0.6614 | 66.14% |
Glucocorticoid receptor binding | + | 0.8271 | 82.71% |
Aromatase binding | + | 0.6621 | 66.21% |
PPAR gamma | + | 0.7445 | 74.45% |
Honey bee toxicity | - | 0.7208 | 72.08% |
Biodegradation | - | 0.9750 | 97.50% |
Crustacea aquatic toxicity | + | 0.6200 | 62.00% |
Fish aquatic toxicity | + | 0.9044 | 90.44% |
Proven Targets:
CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
---|---|---|---|---|---|
No proven targets yet! |
Predicted Targets (via Super-PRED):
CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
---|---|---|---|---|
CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 99.10% | 96.09% |
CHEMBL335 | P18031 | Protein-tyrosine phosphatase 1B | 97.21% | 95.17% |
CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 97.14% | 85.14% |
CHEMBL5747 | Q92793 | CREB-binding protein | 96.85% | 95.12% |
CHEMBL2635 | P51452 | Dual specificity protein phosphatase 3 | 95.81% | 94.00% |
CHEMBL4895 | P30530 | Tyrosine-protein kinase receptor UFO | 94.80% | 90.95% |
CHEMBL2373 | P21730 | C5a anaphylatoxin chemotactic receptor | 93.31% | 92.62% |
CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 93.30% | 94.45% |
CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 92.55% | 86.33% |
CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 92.19% | 95.89% |
CHEMBL2581 | P07339 | Cathepsin D | 90.63% | 98.95% |
CHEMBL5339 | Q5NUL3 | G-protein coupled receptor 120 | 90.32% | 95.78% |
CHEMBL1951 | P21397 | Monoamine oxidase A | 90.29% | 91.49% |
CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 89.86% | 95.89% |
CHEMBL6175 | Q9H3R0 | Lysine-specific demethylase 4C | 89.74% | 96.69% |
CHEMBL2535 | P11166 | Glucose transporter | 89.38% | 98.75% |
CHEMBL1741221 | Q9Y4P1 | Cysteine protease ATG4B | 89.07% | 87.50% |
CHEMBL4303 | P08238 | Heat shock protein HSP 90-beta | 89.02% | 96.77% |
CHEMBL241 | Q14432 | Phosphodiesterase 3A | 88.86% | 92.94% |
CHEMBL1163125 | O60885 | Bromodomain-containing protein 4 | 88.55% | 97.31% |
CHEMBL264 | Q9Y5N1 | Histamine H3 receptor | 87.75% | 91.43% |
CHEMBL225 | P28335 | Serotonin 2c (5-HT2c) receptor | 87.26% | 89.62% |
CHEMBL5555 | O00767 | Acyl-CoA desaturase | 86.93% | 97.50% |
CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 86.39% | 99.17% |
CHEMBL5409 | Q8TDU6 | G-protein coupled bile acid receptor 1 | 86.18% | 93.65% |
CHEMBL2730 | P21980 | Protein-glutamine gamma-glutamyltransferase | 86.05% | 92.38% |
CHEMBL261 | P00915 | Carbonic anhydrase I | 84.84% | 96.76% |
CHEMBL2096618 | P11274 | Bcr/Abl fusion protein | 84.45% | 85.83% |
CHEMBL2094127 | P06493 | Cyclin-dependent kinase 1/cyclin B | 84.19% | 96.00% |
CHEMBL5925 | P22413 | Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 | 84.10% | 92.38% |
CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 84.08% | 93.10% |
CHEMBL3091268 | Q92753 | Nuclear receptor ROR-beta | 83.77% | 95.50% |
CHEMBL5311 | P37023 | Serine/threonine-protein kinase receptor R3 | 83.76% | 82.67% |
CHEMBL4306 | P22460 | Voltage-gated potassium channel subunit Kv1.5 | 83.76% | 94.03% |
CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 83.61% | 89.00% |
CHEMBL4040 | P28482 | MAP kinase ERK2 | 83.01% | 83.82% |
CHEMBL2335 | P42785 | Lysosomal Pro-X carboxypeptidase | 82.29% | 100.00% |
CHEMBL4835 | P00338 | L-lactate dehydrogenase A chain | 81.95% | 95.34% |
CHEMBL2056 | P21728 | Dopamine D1 receptor | 81.76% | 91.00% |
CHEMBL235 | P37231 | Peroxisome proliferator-activated receptor gamma | 81.41% | 95.39% |
CHEMBL1966 | Q02127 | Dihydroorotate dehydrogenase | 80.82% | 96.09% |
CHEMBL3192 | Q9BY41 | Histone deacetylase 8 | 80.56% | 93.99% |
CHEMBL3891 | P07384 | Calpain 1 | 80.36% | 93.04% |
CHEMBL3476 | O15111 | Inhibitor of nuclear factor kappa B kinase alpha subunit | 80.22% | 95.83% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
Isopyrum thalictroides |
PubChem | 10395125 |
LOTUS | LTS0144740 |
wikiData | Q104913217 |